Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies, and clues behind why ...

An enhanced model that integrates non-AJCC clinical features provides clinicians with a more accurate tool for identifying high-risk patients with MCC.

Your Cancer shell could easily transform into your love den between now and February 14—with a new, winter playmate or your dearly beloved. On Wednesday, the year’s only new moon in Aquarius ...

The objective tumor response rates (OTRRs ... according to the 8th edition of the AJCC. Sites of metastatic disease included the liver (73%), pulmonary tract (28%), peritoneum (21%), and other (28%).

The 5-year relative survival rate is low at about 3%, and patients with advanced pancreatic cancer, who have a high recurrence rate, are now able to experience a new treatment method that ...

Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial Colorectal cancer (CRC) remains a major global ...

Thyroid cancer is cancer of the thyroid gland in the neck. Thyroid cancer affects women more often than men. It has a good prognosis. Risk factors include a family history of this cancer, radiation ...

A student whose persistent knee pain turned out to be a rare bone cancer has had her leg amputated in a life-saving operation after it suddenly ballooned in size. Alicia Ortstad, a salad shop ...

BACKGROUND: Pancreatic neuroendocrine tumors (PNETs) are uncommon and heterogeneous neoplasms, often exhibiting indolent biological behavior. Their incidence is rising, largely due to the widespread ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five years after diagnosis; for women it is 14%. In pancreatic cancer ...

Distant metastasis is the major cause of gastric cancer mortality, and epidermal growth factor receptor (EGFR) activation plays critical roles in gastric cancer dissemination. However, EGFR targeting ...

The TP53 gene is a gene that is mutated in many cancers. It is the most common gene mutation found in cancer cells. A tumor-suppressor gene, TP53 codes for a protein that inhibits the development and ...